- Trials with a EudraCT protocol (1,233)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,233 result(s) found for: Bone Biopsy.
Displaying page 1 of 62.
EudraCT Number: 2012-004285-18 | Sponsor Protocol Number: 00002 | Start Date*: 2012-11-08 |
Sponsor Name:Helsingin yliopisto | ||
Full Title: The pain relieving effect of nitrous oxide during bone marrow aspiration and biopsy - a placebo-controlled and randomized trial | ||
Medical condition: This study is performed on adult patients with suspected or known hematologic disease undergoing bone marrow aspiration and biopsy. Study investigates inhaled mixture of nitrous oxide and oxygen in... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021811-17 | Sponsor Protocol Number: 00001 | Start Date*: 2010-10-18 |
Sponsor Name:Helsingin yliopisto [...] | ||
Full Title: Suun limakalvolle annosteltu fentanyyli luuydinaspiraatioon ja -biopsiaan liittyvän kivun hoidossa | ||
Medical condition: This study is performed on adult patients with suspected or known hematologic disease undergoing bone marrow aspiration and biopsy. Study investigates oral transmucosal fentanyl in the treatment of... | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005410-21 | Sponsor Protocol Number: RAE03 | Start Date*: 2006-04-20 |
Sponsor Name:Bradford Teaching Hospitals NHS Foundation Trust | ||
Full Title: Improving the Patient's Experience of a Bone Marrow Biopsy - An evidence based approach to service improvement. | ||
Medical condition: Procedural pain experienced during bone marrow biopsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002782-37 | Sponsor Protocol Number: ENT05 | Start Date*: 2005-11-17 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: A Randomised Trial of Inhaled Entonox Plus Local Anaesthesia Versus Intravenous Midazolam Plus Local Anaesthesia To Improve Pain Control During Bone Marrow Biopsy | ||
Medical condition: This study will involve a group of patients requiring diagnostic bone marrow aspiration and biopsy. The reasons for these will include haematological abnormalities of the blood count , which may be... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006964-48 | Sponsor Protocol Number: 20040215 | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects with Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone | |||||||||||||
Medical condition: Giant Cell Tumor (GCT) of bone | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002312-41 | Sponsor Protocol Number: MK-3475-365 | Start Date*: 2016-10-22 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | |||||||||||||
Full Title: Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) | |||||||||||||
Medical condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: ES (Temporarily Halted) DE (Trial now transitioned) GB (GB - no longer in EU/EEA) FR (Ongoing) SE (Trial now transitioned) DK (Trial now transitioned) IE (Trial now transitioned) IT (Ongoing) PL (Trial now transitioned) NL (Ongoing) AT (Trial now transitioned) FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001041-17 | Sponsor Protocol Number: 20060289 | Start Date*: 2007-09-11 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety and Sustained Efficacy of Denosumab (AMG162) in the Treatment of Postmenopausal Osteoporosis | |||||||||||||
Medical condition: Treatment of postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) EE (Completed) DE (Completed) LV (Completed) GB (Completed) LT (Completed) HU (Completed) AT (Completed) FI (Completed) BE (Completed) MT (Completed) CZ (Completed) FR (Completed) ES (Completed) GR (Completed) IT (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005096-27 | Sponsor Protocol Number: MBPS205 | Start Date*: 2017-06-23 | |||||||||||
Sponsor Name:Mereo BioPharma 3 Ltd. | |||||||||||||
Full Title: A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, incorporating an open label substudy, in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with setrusu... | |||||||||||||
Medical condition: Osteogenesis imperfecta | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (GB - no longer in EU/EEA) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003888-56 | Sponsor Protocol Number: 20192022 | Start Date*: 2021-01-30 | |||||||||||
Sponsor Name:Department of Nephrology, Herlev & Gentofte Hospital, Herlev Hospital | |||||||||||||
Full Title: Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005160-34 | Sponsor Protocol Number: MV-1-2017 | Start Date*: 2017-04-21 | |||||||||||||||||||||
Sponsor Name:Universitetsklinikken for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro, Hospitalsenheden Vest | |||||||||||||||||||||||
Full Title: 18F-NaF PET/CT in combination with biomarkers for the classification of renal osteodystrophy in chronic kidney disease | |||||||||||||||||||||||
Medical condition: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially renal osteodystofi. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-018543-34 | Sponsor Protocol Number: 12153599 | Start Date*: 2010-06-11 | |||||||||||
Sponsor Name:Orthopaedic Syrgery Unit Northern Jytland | |||||||||||||
Full Title: NSAIDs INFLUENCE ON HEAL OF COLLES FRACTURE | |||||||||||||
Medical condition: Ivestigations hypotheses: 1. NSAIDs provide a significant postoperative pain relief that can make mobilization / rehabilitation faster and easier oedema prophylaxis. 2. NSAIDs do not affect bone he... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014456-29 | Sponsor Protocol Number: Cord01 | Start Date*: 2009-09-25 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: PHASE II STUDY OF LAPATINIB IN EGFR/HER2NEU POSITIVE ADVANCED CHORDOMA | |||||||||||||
Medical condition: Advanced chordoma EGFR/Her2Neu positive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006692-20 | Sponsor Protocol Number: independant Trial (TOMIBA-TRIAL01) | Start Date*: 2007-09-06 |
Sponsor Name:St. Vincent Hospital, Medical Department II | ||
Full Title: The TOMIBA study Treatment of Osteoporotic Men With Intravenous Ibandronate An open-label, single-center, prospective Phase III study | ||
Medical condition: Osteoporosis in Men | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002483-31 | Sponsor Protocol Number: UZBRU_VHH2_2 | Start Date*: 2020-11-30 |
Sponsor Name:UZ Brussel | ||
Full Title: Phase II study to evaluate the clinical potential of 68GaNOTA-Anti-MMR-VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in oncological lesions, ... | ||
Medical condition: C1: malignancies of the head and neck. C2: malignancy with a solid component C3: carotid plaque, planned for (SOC) carotid endarterectomy. C4: biopsy-proven Hodgkin or non-Hodgkin lymphoma. C5: su... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003620-37 | Sponsor Protocol Number: STH19580 | Start Date*: 2019-10-31 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: NEPTUNE: Enhancement of immuNothEraPy combining avelumab and repeaT doses of radiUm-223 in ER+ve, HER2-ve metastatic breast caNcEr. | |||||||||||||
Medical condition: ER+ve HER-ve breast cancer with bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004840-21 | Sponsor Protocol Number: RISED_C_00935 | Start Date*: 2007-04-23 | |||||||||||
Sponsor Name:sanofi-aventis Netherlands B.V. | |||||||||||||
Full Title: Bone Histomorphometry, Microarchitecture and Matrix Structure and Properties in Patients Receiving Long-term Risedronate Treatment | |||||||||||||
Medical condition: The objective of this study is to collect data on bone histomorphometry, architecture, turnover and material properties from iliac crest biopsies taken from postmenopausal women after > 5 year rise... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005088-17 | Sponsor Protocol Number: CZOL446EHU03 | Start Date*: 2005-05-26 |
Sponsor Name:Novartis Hungária Ltd. | ||
Full Title: A multicenter, Open-label Study to Determine the Effect of I.V. Zometa on Pain and Quality of Life in Patients with Bone Metastases with or without Skeletal Related Events (SREs) Resulting from Bre... | ||
Medical condition: Patients will have bone metastases with or without skeletal related events (SREs) from breast cancer and prostate cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001222-26 | Sponsor Protocol Number: 2013-1 | Start Date*: 2013-08-08 |
Sponsor Name:Aalborg University Hospital | ||
Full Title: Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) and the effect of antiresorptive treatment on glycemic markers. | ||
Medical condition: Diabetes Mellitus and Osteopenia/Osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002370-23 | Sponsor Protocol Number: CL2-12911-039 | Start Date*: 2011-11-30 | ||||||||||||||||
Sponsor Name:INSTITUT DE RECHERCHES INTERNATIONALES SERVIER | ||||||||||||||||||
Full Title: A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelli... | ||||||||||||||||||
Medical condition: Dental implantation in osteoporotic patients or in patients at risk of osteoporotic fracture. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004046-41 | Sponsor Protocol Number: 273551 | Start Date*: 2021-12-09 |
Sponsor Name:University of Bergen, | ||
Full Title: A multicentre clinical trial; Alveolar bone augmentation using Mesenchymal Stem Cells and biphasic calcium phosphate granules prior to dental implants | ||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.